leading glp-1 treatments for diabetes 2025 New Guidelines Type 2 in GLP-1s and Diabetes Care: What

Antioxid Redox Signal 15: 285565

This information should not replace your doctor's advice

Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk

Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available

These mechanisms help regulate blood sugar and reduce caloric intake

References Baggio, L